H. Lacroix

发表

Phase I/II study of monoclonal antibody against Lewis Y hapten in relapsed small-cell lung cancer.

R. Stahel, J. Sculier, H. Loibner, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results.

D. Dunlop, D. Talbot, W. Steward, 1996, Seminars in oncology.

Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases.

M. Kraus, J. Iglehart, M. Skinner, 1989, Oncogene.

Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer

M. Paesmans, J. Sculier, J. Body, 1990, Cancer.

A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.

J. Sculier, J. Body, J. Dumon, 1989, Henry Ford Hospital medical journal.

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

J. Sculier, J. Klastersky, H. Lacroix, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Sarcomas management network in France].

H. Lacroix, F. Gouin, 2010, Bulletin du cancer.

[Efficacy of the combination of mitomycin, ifosfamide and cisplatin with irradiation for the treatment of cerebral metastasis in non small cell lung carcinoma].

J. Dutin, H. Lacroix, G. Dabouis, 1995, Bulletin du cancer.

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

P. Couzigou, M. Ducreux, C. Borel, 2018, European journal of cancer.

Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients.

Jaafar Bennouna, Jean-Yves Douillard, J. Douillard, 2013, Lung cancer.

Blood transfusion plus allograft--but not blood transfusion alone--induce IL 2-producing suppressor cells in Lew-1A recipients of LEW-1W heart allograft.

J. Moreau, J. Soulillou, H. Lacroix, 1987, Transplantation proceedings.

Docetaxel (Taxotere) - an update.

H. Lacroix, C. Ligeza, 1998, Expert Opinion on Investigational Drugs.

Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results of an ongoing phase I/II study

D. Dunlop, D. Talbot, W. Steward, 1995, Anti-cancer drugs.